Bone turnover decreases and bone structure improves during treatment with weekly high-dose methylprednisolone for 12 weeks in Graves’ orbitopathy

PURPOSE: Weekly treatment with the intravenous glucocorticoid methylprednisolone for 12 weeks is mainstay in the treatment of Graves’ orbitopathy but may decrease bone mass and impair bone structure. We therefore investigated bone turnover, -mass and -structure during the treatment cause in these pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Harsløf, Torben, Hikmet, Rawan, Ebbehøj, Eva, Langdahl, Bente
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618317/
https://www.ncbi.nlm.nih.gov/pubmed/37676399
http://dx.doi.org/10.1007/s12020-023-03494-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10618317/
https://www.ncbi.nlm.nih.gov/pubmed/37676399
http://dx.doi.org/10.1007/s12020-023-03494-5

Ejemplares similares